Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jul 26, 2022; 10(21): 7302-7313
Published online Jul 26, 2022. doi: 10.12998/wjcc.v10.i21.7302
Table 1 Demographical characteristics and clinical data of the patients
Variables
DICH group (n = 26)
Non-DICH group (n = 133)
P value
Age (yr)51.35 ± 12.0853.89 ± 15.170.422
Male gender, n (%)17 (65.38)66 (49.62)0.141
Primary intracranial lesion, n (%)0.679
Traumatic brain injury6 (23.07)43 (17.29)
Intracranial hemorrhage5 (19.23)30 (22.56)
SAH (aneurysm rupture)10 (38.46)29 (21.80)
SAH (AVM rupture)0 (0)0 (0)
Cerebral infarction 0 (0)0 (0)
Tumor2 (7.69)8 (6.02)
Infection 0 (0)4 (3.01)
Primary hydrocephalus3 (11.54)19 (14.29)
Pre-Craniotomy, n (%)9 (34.62)56 (42.11)0.477
Pre-Decompression, n (%)8 (30.77)50 (37.59)0.508
Pre-EVD, n (%)16 (61.54)42 (31.58)0.004a
Pre-Cranioplasty, n (%)2 (7.69)23 (17.29)0.350
LP pressure (mmH2O)141.54 ± 60.93139.42 ± 64.940.878
CSF protein (g/L)0.56 ± 0.460.64 ± 0.600.509
CSF glucose (mmol/L)3.87 ± 1.453.88 ± 1.350.980
CSF nucleated cells (106/L)16.31 ± 20.1611.68 ± 17.150.223
WBC (109/L)8.37 ± 3.107.97 ± 2.820.512
Neutrophils (109/L)5.55 ± 2.975.41 ± 2.630.810
Lymphocyte (109/L)1.89 ± 0.551.75 ± 0.590.237
NLR3.40 ± 2.793.48 ± 2.200.869
RBC (1012/L)4.04 ± 1.543.88 ± 0.690.407
HGB (g/L)112.88 ± 15.44114.71 ± 18.150.631
PLT (109/L)276.31 ± 68.61280.92 ± 102.980.827
PLR160.46 ± 69.01184.02 ± 105.170.275
PT(s)11.64 ± 1.2411.40±1.260.374
INR1.01 ± 0.110.99 ± 0.110.382
Fib (g/L)4.88 ± 7.403.67 ± 1.600.416
Potassium (mmol/L)3.85 ± 0.423.81 ± 0.430.680
Sodium (mmol/L)136.68 ± 5.19138.34 ± 5.300.144
Calcium (mmol/L)2.23 ± 0.122.22 ± 0.170.796
Blood glucose (mmol/L)5.92 ± 1.456.17 ± 2.340.591
SBP (mmHg)137.46 ± 21.35140.14 ± 24.840.609
DBP (mmHg)86.50 ± 13.2285.71 ± 14.080.791
Hypertension, n (%)10 (38.46)49 (36.84)0.876
Other basic disease, n (%)3 (11.54)16 (12.03)1.000
Smoker, n (%)7 (26.92)31 (23.31)0.693
Prior Blood transfusion, n (%)6 (23.08)48 (36.09)0.200
Operation time (min)73.46 ± 34.5874.35 ± 26.860.883
Location of VP shunt, n (%)0.250
Frontal 23 (88.46)101 (75.94)
Occiptal3 (11.54)32 (24.06)
Other VP Complications, n (%)1 (3.85)10 (7.52)0.801
Brain edema around catheter, n (%)15 (57.69)34 (25.56)0.000a
Pre-mRS, n (%)0.281
Low (0-2)8 (30.77)56 (42.11)
High (3-5)18 (69.23)77 (57.89)
Post-mRS, n (%)0.024
Low (0-2)977
High (3-5)1755
Table 2 Univariate analysis of variable relating to delayed intracranial hemorrhage in ventriculoperitoneal shunt patients
Variables
DICH group (n = 26)
Non-DICH group (n = 133)
P value
Demographics
Age (yr)51.35 ± 12.0853.89 ± 15.170.420
Male gender, n (%)17 (65.38)66 (49.62)0.145
Primary clinical diagnosis, n (%)
Traumatic brain injury6 (23.07)43 (17.29)
Intracranial hemorrhage5 (19.23)30 (22.56)
SAH (aneurysm rupture)10 (38.46)29 (21.80)
SAH (AVM rupture)0 (0)0 (0)
Cerebral infarction 0 (0)0 (0)
Tumor2 (7.69)8 (6.02)
Infection 0 (0)4 (3.01)
Primary hydrocephalus3 (11.54)19 (14.29)
Pre-Craniotomy, n (%)9 (34.62)56 (42.11)0.479
Pre-Decompression, n (%)8 (30.77)50 (37.59)0.510
Pre-EVD, n (%)16 (61.54)42 (31.58)0.005a
Pre-Cranioplasty, n (%)2 (7.69)23 (17.29)0.233
LP pressure (mmH2O)141.54 ± 60.94139.42 ± 64.940.877
CSF protein (g/L)0.56 ± 0.460.64 ± 0.600.509
CSF glucose (mmol/L)3.87 ± 1.453.88 ± 1.350.980
CSF nucleated cells (106/L)16.31 ± 20.1611.68 ± 17.150.229
WBC (109/L)8.37 ± 3.107.97 ± 2.820.510
Neutrophils (109/L)5.55 ± 2.975.41 ± 2.630.808
Lymphocyte (109/L)1.89 ± 0.551.75 ± 0.590.237
NLR3.40 ± 2.793.48 ± 2.200.868
RBC (1012/L)4.04 ± 1.543.88 ± 0.690.415
HGB (g/L)112.88 ± 15.44114.71 ± 18.150.629
PLT (109/L)276.31 ± 68.61280.92 ± 102.970.826
PLR160.46 ± 69.01184.02 ± 105.170.276
PT(s)11.64 ± 1.2411.40 ± 1.260.373
INR1.01 ± 0.110.99 ± 0.110.381
Fib (g/L)4.88 ± 7.403.67 ± 1.600.183
Potassium (mmol/L)3.85 ± 0.423.81 ± 0.430.678
Sodium (mmol/L)136.68 ± 5.19138.34 ± 5.300.145
Calcium (mmol/L)2.23 ± 0.122.2238 ± 0.170.795
Blood glucose (mmol/L)5.92 ± 1.456.17 ± 2.340.589
SBP (mmHg)137.46 ± 21.35140.14 ± 24.840.607
DBP (mmHg)86.50 ± 13.2285.71 ± 14.080.790
Hypertension, n (%)10 (38.46)49 (36.84)0.876
Other basic disease, n (%)3 (11.54)16 (12.03)0.944
Smoker, n (%)7 (26.92)31 (23.31)0.693
Prior Blood transfusion, n (%)6 (23.08)48 (36.09)0.205
Operation time (min)73.46 ± 34.5874.35 ± 26.860.882
Location of VP shunt, n (%)0.170
Frontal 23 (88.46)101 (75.94)
Occiptal3 (11.54)32 (24.06)
Other VP complications, n (%)1 (3.85)10 (7.52)0.508
Brain edema around catheter, n (%)15 (57.69)34 (25.56)0.000a
Pre-mRS, n (%)0.523
0-28 (30.77)56 (42.11)
3-518 (69.23)77 (57.89)
Table 3 Multivariate analysis of variable relating to delayed intracranial hemorrhage in ventriculoperitoneal shunt patients
Variable
P value
OR
95%CI
Age (yr)0.1620.9750.942-1.010
Pre-Craniotomy0.5480.7230.250-2.085
Pre-EVD0.0452.8141.024-7.730
PT(s)0.2241.2680.865-1.859
Location of VP shunt0.1532.7750.685-11.249
Brain edema around catheter0.0008.3973.043-23.171
Table 4 Summary of 26 patients with delayed intracranial hemorrhage after ventriculoperitoneal shunt
No.
Age/sex
Primary intracranial lesion
History of EVD
Location of VP shunt
DICH type
Onsetday
Treatment
Pre-mRS
Post-mRS
150/FAneurysmYFrontalIVH2Conservative11
267/MICHYFrontalICH around catheter3Conservative31
364/MAneurysmYFrontalIVH1Conservative11
437/FTumorNOccipitalICH around catheter11Conservative54
556/MTBIYFrontalICH around catheter3Conservative55
623/MTBINFrontalICH around catheter4Conservative55
763/FAneurysmNFrontalICH around catheter7Surgery45
854/MAneurysmYFrontalICH around catheter3Conservative55
961/MAneurysmYOccipitalICH around catheter5Conservative21
1047/MICHYFrontalICH around catheter7Conservative55
1158/MAneurysmYFrontalIVH7Conservative22
1251/FAneurysmNFrontalICH around catheter3Conservative11
1358/MTumorNFrontalICH around catheter2Conservative55
1458/FPrimary hydrocephalusNFrontalSubdural hematoma7Conservative55
1547/MPrimary hydrocephalusNFrontalICH around catheter5Conservative44
1653/MTBIYFrontalIVH2Conservative53
1742/MAneurysmYFrontalICH around catheter9Conservative55
1832/MAneurysmYOccipitalIVH1Conservative22
1945/MTBIYFrontalICH around catheter1Conservative55
2062/MICHYFrontalSubdural hematoma2Conservative55
2147/FTBIYFrontalICH around catheter2Conservative44
2256/MICHNFrontalIVH7Conservative54
2347/MICHNFrontalSubdural hematoma4Surgery 55
2426/FPrimary hydrocephalusYFrontalIVH8Conservative22
2572/FAneurysmYFrontalIVH1Conservative11
2659/FTBINFrontalIVH1Conservative55
Table 5 Summary of the previous studies of delayed intracranial hemorrhage after ventriculoperitoneal shunt
Ref.
Year
DICH
Non-DICH
Number of variables
Proposed risk factors
Hudson et al[18]201887210DAPT (P = 0.0001, OR = 31.23, 95%CI: 2.98-327.32)
Guo et al[15]2017205128Advanced age (P = 0.027, OR = 1.048, 95%CI: 1.005-1.092), craniotomy history (P = 0.025, OR = 3.874, 95%CI: 1.183-12.693), brain edema around the catheter (P < 0.001, OR = 9.056, 95%CI: 3.194-25.675)
Gong et al[16]2017127429Age ≥ 60 yr (P = 0.0008), prior craniotomy operation (P = 0.0001) and manipulation of the valve system (P = 0.0017)
Qian et al[14]20171114018Postoperative LMWH therapy (P = 0.026, relative ratio = 4.8, 95%CI: 1.4-17.1)
Jang et al[17]2018341049Old age (P = 0.037) and delayed PTT (P = 0.032)
Li et al[6]20212910121Elevated NLRR (P < 0.001, OR = 2.792, 95%CI: 1.747-4.460); history of craniotomy (P = 0.010, OR = 3.394, 95%CI: 1.060-10.869)